Authors: Burakgazi AZ PMID: 35702058 PMCID: PMC9149535 doi: 10.1159/000524205 Abstract COVID-19 has caused several neurological complications by affecting the central and peripheral nervous systems (PNS). Studies on the PNS involvement in COVID-19 are limited. These complications are likely unreported, given the difficulty of obtaining further diagnostic information, such as expert neurologist evaluation, electrodiagnostic testing, and [...]

Authors: Abrams RM, Simpson DM, Navis A, Jette N, Zhou L PMID: 34766365 PMCID: PMC8661991 DOI: 10.1002/mus.27458 Abstract Introduction/aims: The development and persistence of neurological symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is referred to as "long-haul" syndrome. We aimed to determine whether small fiber neuropathy (SFN) was associated with SARS-CoV-2 infection. [...]

Authors: Zhou L, Shin S Abstract Small fiber neuropathy (SFN) is common and can be associated with many medical conditions, including reports of an association with COVID-19. A Dutch study suggests a prevalence of 52.95 per 100,000 population that increases with age.1 Standardized diagnostic criteria for SFN are not fully established and skin biopsy [...]

Authors: Levine TD, Kafaie J, Zeidman LA, Saperstein DS, Bland RJ PMID: 31650561 DOI: 10.1002/mus.26748 Abstract Introduction: Causes of small-fiber peripheral neuropathies (SFN) are often undefined. In this study we investigated associations of serum autoantibodies, immunoglobulin G (IgG) vs fibroblast growth factor receptor-3 (FGFR-3), and immunoglobulin M (IgM) vs trisulfated heparan disaccharide (TS-HDS) in cryptogenic [...]

Authors: Bednarik J, Bursova S, Dusek L, Sommer C PMID: 19909481 DOI: 10.1111/j.1529-8027.2009.00229.x Abstract The aim of this study was to evaluate the etiology in a group of 84 patients with painful sensory neuropathy with predominant small-fiber dysfunction (54 men and 30 women, median: 58; range: 25-83 years) recruited from a population of the South [...]